Where is bremelanotide legal?

Bremelanotide, marketed under the brand name Vyleesi, is primarily approved for use in the United States for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It is also available in some other countries, but its legal status can vary. As of my last knowledge update, it's important to check local regulations, as approval and availability may differ from one region to another.